The Biological Effect and Clinical Application of Long Noncoding RNAs in Colorectal Cancer

Colorectal cancer (CRC) is one of the most common malignancies in the world. Easier recurrence and metastasis is the main cause of mortality in CRC patients, and the markers applied for diagnosis and treatment of CRC is still urgently needed to early diagnose and evaluate therapeutic effect. Long noncoding RNA (lncRNA) is a class of noncoding RNA that the length is more than 200 nucleotides. With the development of sequencing technique about transcriptome, increasing lncRNAs are focused on their function and mechanism related to the nosogenesis and pathology of CRC. Recent studies report that lncRNAs acted as crucial role in CRC and could be as biomarker for CRC diagnosis and treatment. In this review, we display the regulation of lncRNA by interacting with DNA, RNA and protein and highlight the double role of lncRNAs as oncogene or anti-tumor gene involved in Wnt signaling pathway, p53 signaling pathway or others to be an regulator in CRC development. Lastly, we discuss some new finding of lncRNAs, especially lncRNA in exosome, which could be as potential markers for diagnosis and treatment of CRC in future.

[1]  S. Sajdak,et al.  Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer. , 2017, European journal of medicinal chemistry.

[2]  T. Petrova,et al.  Microenvironmental regulation of tumour angiogenesis , 2017, Nature Reviews Cancer.

[3]  S. Shabalina,et al.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3 , 2017, eLife.

[4]  Yangjian,et al.  Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. , 2017 .

[5]  Qing Zhai,et al.  The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway , 2017, Cellular Physiology and Biochemistry.

[6]  Chu-qiang Li,et al.  The novel long intergenic noncoding RNA UCC promotes colorectal cancer progression by sponging miR-143 , 2017, Cell Death & Disease.

[7]  Xin Wang,et al.  H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1. , 2017, International journal of oncology.

[8]  Shan Wang,et al.  Long non-coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer. , 2017, Oncology letters.

[9]  P. Lazo.  Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression. , 2017, Cellular signalling.

[10]  Hairong Liang,et al.  LincRNa-p21: function and mechanism in cancer , 2017, Medical Oncology.

[11]  C. Fan,et al.  Genome-wide analysis of long non-coding RNA expression and function in colorectal cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  D. S. Pandey,et al.  p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Gan Zhang,et al.  The long noncoding RNA‐ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR‐145 pathway , 2017, Journal of gastroenterology and hepatology.

[14]  He Li,et al.  Roles of long noncoding RNAs in colorectal cancer metastasis , 2017, Oncotarget.

[15]  Z. Zong,et al.  Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3 , 2017, Oncotarget.

[16]  Hong Zhou,et al.  Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway , 2017, Oncotarget.

[17]  Haisheng Peng,et al.  Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. , 2017, Translational research : the journal of laboratory and clinical medicine.

[18]  Hong Li,et al.  Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53 , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[19]  R. Hollingsworth,et al.  Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies , 2017, Oncogene.

[20]  Jing Zhu,et al.  H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells , 2017, Neoplasia.

[21]  Jian Zhao,et al.  The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.

[22]  Qian Li,et al.  Variable Levels of Long Noncoding RNA Expression in DNA Mismatch Repair-Proficient Early-Stage Colon Cancer , 2017, Digestive Diseases and Sciences.

[23]  Zhonghua Ma,et al.  Long non‐coding RNA FOXP4‐AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer , 2017, Cell proliferation.

[24]  X. Bai,et al.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling , 2017, Molecular Cancer.

[25]  Xiaoming Jin,et al.  The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing β-Catenin Expression in Colorectal Cancer , 2017, BioMed research international.

[26]  Yifan Lian,et al.  Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer , 2017, Oncogenesis.

[27]  Xin Hu,et al.  Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo , 2016, Oncotarget.

[28]  R. Simpson,et al.  Transcriptome and long noncoding RNA sequencing of three extracellular vesicle subtypes released from the human colon cancer LIM1863 cell line , 2016, Scientific Reports.

[29]  K. Matsuura,et al.  Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology , 2016, Journal of Translational Medicine.

[30]  L. Du,et al.  Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer , 2016, Oncotarget.

[31]  Jae Kwan Lee,et al.  The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer , 2016, Oncotarget.

[32]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[33]  Dan Zhao,et al.  Clinical significance of HOTAIR expression in colon cancer. , 2016, World journal of gastroenterology.

[34]  Hui Zhou,et al.  Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling , 2016, Oncotarget.

[35]  Gui-yuan Li,et al.  Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer , 2016, Oncotarget.

[36]  Daici Chen,et al.  Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis. , 2016, International journal of oncology.

[37]  Zhijian Zhang,et al.  Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer , 2016, Cellular Physiology and Biochemistry.

[38]  S. Lipkin,et al.  A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division , 2016, eLife.

[39]  M. Ballantyne,et al.  lncRNA/MicroRNA interactions in the vasculature , 2016, Clinical pharmacology and therapeutics.

[40]  Xu Gao,et al.  Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3 , 2016, Oncotarget.

[41]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[42]  Tao Yu,et al.  Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer , 2015, Oncotarget.

[43]  S. Babashah,et al.  Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. , 2015, European journal of cancer.

[44]  Huamin Wang,et al.  Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α , 2015, Gut.

[45]  J. Bradner.  Cancer: An essential passenger with p53 , 2015, Nature.

[46]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[47]  R. Kong,et al.  Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer , 2015, Tumor Biology.

[48]  H-S Liu,et al.  Autophagy-preferential degradation of MIR224 participates in hepatocellular carcinoma tumorigenesis , 2014, Autophagy.

[49]  Jian Chen,et al.  Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. , 2014, Oncology reports.

[50]  E. White,et al.  Autophagy-Mediated Tumor Promotion , 2013, Cell.

[51]  O. Fodstad,et al.  Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. , 2013, Clinical colorectal cancer.

[52]  M. L. Alvarez,et al.  Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy , 2013, PloS one.

[53]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[54]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[55]  Zunnan Huang,et al.  Long non-coding RNA: a new player in cancer , 2013, Journal of Hematology & Oncology.

[56]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[57]  Yiran Huang,et al.  Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. , 2013, Molecular bioSystems.

[58]  H. Clevers,et al.  Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.

[59]  Edith Heard,et al.  Recent advances in X-chromosome inactivation research. , 2012, Current opinion in cell biology.

[60]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[61]  Kotb Abdelmohsen,et al.  LincRNA-p21 suppresses target mRNA translation. , 2012, Molecular cell.

[62]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[63]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[64]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[65]  E. Lalli,et al.  The Wnt/beta-catenin pathway in adrenocortical development and cancer , 2011, Molecular and Cellular Endocrinology.

[66]  J. Rinn,et al.  A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.

[67]  M. Gerstein,et al.  Annotating non-coding regions of the genome , 2010, Nature Reviews Genetics.

[68]  Leonard Lipovich,et al.  Genome-wide computational identification and manual annotation of human long noncoding RNA genes. , 2010, RNA.

[69]  A. Gabory,et al.  The H19 locus: Role of an imprinted non‐coding RNA in growth and development , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[70]  M. Nalls,et al.  Evidence for natural antisense transcript-mediated inhibition of microRNA function , 2010, Genome Biology.

[71]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[72]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[73]  Changning Liu,et al.  MicroRNA-encoding long non-coding RNAs , 2008, BMC Genomics.

[74]  D. Yee,et al.  Disrupting insulin-like growth factor signaling as a potential cancer therapy , 2007, Molecular Cancer Therapeutics.

[75]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[76]  C. Roberts,et al.  The insulin-like growth factor system and cancer. , 2003, Cancer letters.

[77]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[78]  R. Reinhardt,et al.  Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. , 2000, Human molecular genetics.

[79]  Zhao-yang Yang,et al.  LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression. , 2017, Cancer biomarkers : section A of Disease markers.

[80]  Youming Li,et al.  Epidemiological Trends in Colorectal Cancer in China: An Ecological Study , 2016, Digestive Diseases and Sciences.

[81]  S. Hou,et al.  Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer. , 2016, Neoplasma.

[82]  H. Tao.  Long noncoding RNAs in colorectal cancer , 2014 .

[83]  J. Lawrence,et al.  XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome. , 2010, Cold Spring Harbor symposia on quantitative biology.

[84]  K. Arney.  H19 and Igf2--enhancing the confusion? , 2003, Trends in genetics : TIG.